The Embry Law Firm is currently reviewing cases related to the drug Elmiron and patients experiencing serious eye injuries. Some studies suggest that as many as 25 percent of patients taking Elmiron have developed some form of eye condition.
If you have taken Elmiron and are suffering from vision impairment or loss, contact us to find out more about your legal rights and options.
Elmiron was approved by the U.S. Food and Drug Administration (FDA) in 1996. Since then, millions of patients have been prescribed the medication for treatment of interstitial cystitis (IC). IC is a painful bladder syndrome.
While Elmiron is considered successful in treating the symptoms of IC, it has caused devastating eye injuries to thousands of patients. Patients taking Elmiron report experiencing a variety of eye issues:
These symptoms result from an eye disease called retinal maculopathy.
Since Elmiron entered the market, thousands of patients have been diagnosed with this disorder and these symptoms. Retinal maculopathy involves degeneration of the macula, or the central portion of the retina. In the early stages, the patient may experience blurred vision or other minor impairments. As the disease progresses, however, the patient may experience partial or total blindness.
Retinal maculopathy is a relatively new disease. It was first discovered in 2015 by doctors at Emory Eye Center in Atlanta. Doctors found an eye condition in six women that they had not seen before. This disease didn’t have the same identifiable cause as other degenerative disorders. Studies ensued, and in 2018, scientists found the link between Elmiron and retinal maculopathy.
Patients are filing lawsuits against Janssen Pharmaceuticals, the manufacturer, because of their failure to warn consumers of the potential risk. According to lawsuits, Janssen did not tell patients that there is a risk of eye problems. In fact, it was not included on the drug label until 2020, despite there being evidence proving the link.
In June 2020, Janssen updated the Elmiron label to include possible side effects:
The label provides more information but still does not mention retinal maculopathy as a potential side effect. Instead, the label urges patients to have their eyesight checked routinely.
Patients feel that they were misled and put themselves at risk without the ability to weigh their options more carefully. Sadly, there are likely many more instances of eye injuries related to Elmiron than what is currently known. There could be millions of people at risk for this devastating eye disease.
The best way to find out if you qualify to file an Elmiron injury lawsuit is to speak with a lawyer who understands Georgia state law and the nature of these cases. Filing a legal claim against a pharmaceutical company like Janssen (a Johnson & Johnson subsidiary) is no easy task. Your eligibility to file a lawsuit, and their liability for your injuries, will be fought at every turn. Pharmaceutical companies have a lot of legal resources, so you can bet that they will mount a tough defense.
That’s why you need the help of a skilled Georgia Elmiron Injury lawyer. At The Embry Law Firm, we will thoroughly review the details of your case and determine if you qualify to take legal action. Our Georgia Elmiron injury lawyer will:
We will be by your side through every step of the legal process. We are here for you. Call us to find out more about how we can help you. Schedule your free consultation by calling (844) 443-6279.